The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
- PMID: 25510679
- DOI: 10.1038/ncomms6852
The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
Abstract
Angiogenesis, activation of metastasis and avoidance of immune destruction are important for cancer progression. These biological capabilities are, apart from cancer cells, mediated by different cell types, including endothelial, haematopoietic progenitor and myeloid-derived suppressor cells. We show here that all these cell types frequently express the Wilms' tumour suppressor Wt1, which transcriptionally controls expression of Pecam-1 (CD31) and c-kit (CD117). Inducible conditional knockout of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause regression of tumour vascularization and an enhanced immune response, leading to decreased metastasis, regression of established tumours and enhanced survival. Thus, Wt1 is an important regulator of cancer growth via modulation of tumour vascularization, immune response and metastasis formation.
Similar articles
-
Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.PLoS One. 2013;8(1):e53131. doi: 10.1371/journal.pone.0053131. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372655 Free PMC article.
-
Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.J Immunol. 2013 Mar 1;190(5):2415-23. doi: 10.4049/jimmunol.1202535. Epub 2013 Jan 23. J Immunol. 2013. PMID: 23345334 Free PMC article.
-
The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo.Oncogene. 2008 Jun 12;27(26):3662-72. doi: 10.1038/sj.onc.1211044. Epub 2008 Jan 21. Oncogene. 2008. PMID: 18212735
-
Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation.Pflugers Arch. 2009 Jun;458(2):315-23. doi: 10.1007/s00424-008-0621-3. Epub 2008 Dec 4. Pflugers Arch. 2009. PMID: 19052773 Review.
-
The WT1 gene--its role in tumourigenesis and prospects for immunotherapeutic advances.In Vivo. 2014 Sep-Oct;28(5):675-81. In Vivo. 2014. PMID: 25189877 Review.
Cited by
-
Combinational Pulsing of TAAs Enforces Dendritic Cell-Based Immunotherapy through T-Cell Proliferation and Interferon-γ Secretion in LLC1 Mouse Model.Cancers (Basel). 2024 Jan 18;16(2):409. doi: 10.3390/cancers16020409. Cancers (Basel). 2024. PMID: 38254898 Free PMC article.
-
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.PLoS Pathog. 2024 Jan 8;20(1):e1011881. doi: 10.1371/journal.ppat.1011881. eCollection 2024 Jan. PLoS Pathog. 2024. PMID: 38190392 Free PMC article.
-
Cell atlas of CCl 4-induced progressive liver fibrosis reveals stage-specific responses.Zool Res. 2023 May 18;44(3):451-466. doi: 10.24272/j.issn.2095-8137.2023.031. Zool Res. 2023. PMID: 36994536 Free PMC article.
-
Immunomodulatory effects of extracellular vesicles in glioblastoma.Front Cell Dev Biol. 2022 Nov 16;10:996805. doi: 10.3389/fcell.2022.996805. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36467419 Free PMC article. Review.
-
Regulation of Mesothelial Cell Fate during Development and Human Diseases.Int J Mol Sci. 2022 Oct 8;23(19):11960. doi: 10.3390/ijms231911960. Int J Mol Sci. 2022. PMID: 36233262 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
